Transactions
September 11 2013
Enclarity Acquired By LexisNexis
Company Description
Enclarity is the largest, most accurate “single book of truth” for medical provider business and professional information on over 6.5 million providers in the United States. The Company delivers its provider information solutions by combining public and proprietary data sources, advanced analytics, data science, and industry expertise. These provider information solutions enable several important initiatives across the payer, provider, government, and life sciences markets:
- Establishes significant operating efficiencies and cost reductions within payer claims workflow processes
- Improves business operations, master data management (MDM), and data warehousing for advanced BI/data analytics
- Triggers key indicators in wide-scale detection of fraud, waste, and abuse
- Enhances marketing strategies, sales force optimization and prescriber validation used by life sciences organizations in targeting strategies
- Develops a single, reliable portal of provider information look-up for consumers exploring insurance exchange plan enrollment
- Streamlines pharma and device manufacturer compliance and regulatory management
Objectives
Enclarity and its investors, including Bain Capital and Ignition Capital, engaged TripleTree to help evaluate and assess the Company’s strategic options. Recognizing the significant need for data management, data integrity, and information analytics solutions across multiple healthcare market segments, Enclarity sought a strategic partner with the ability to immediately create new opportunities for their solutions.
Results
After assessing multiple options, Enclarity found LexisNexis to be the ideal partner given their existing analytics platform and commitment to cost containment and transparency. Enclarity will combine with LexisNexis’ Risk Solutions business unit, which offers risk management and fraud prevention products across multiple industries, including healthcare. With the acquisition of Enclarity, LexisNexis becomes a leader in provider data, enabling cost containment through fraud, waste, and abuse prevention and detection while also improving clinical outcomes through identity management, predictive modeling, and clinical analytics.
LEAD INVESTMENT BANKERS
Jason Grais
Brian Klemenhagen
Scott Donahue
Company Description
Enclarity is the largest, most accurate “single book of truth” for medical provider business and professional information on over 6.5 million providers in the United States. The Company delivers its provider information solutions by combining public and proprietary data sources, advanced analytics, data science, and industry expertise. These provider information solutions enable several important initiatives across the payer, provider, government, and life sciences markets:
- Establishes significant operating efficiencies and cost reductions within payer claims workflow processes
- Improves business operations, master data management (MDM), and data warehousing for advanced BI/data analytics
- Triggers key indicators in wide-scale detection of fraud, waste, and abuse
- Enhances marketing strategies, sales force optimization and prescriber validation used by life sciences organizations in targeting strategies
- Develops a single, reliable portal of provider information look-up for consumers exploring insurance exchange plan enrollment
- Streamlines pharma and device manufacturer compliance and regulatory management
Objectives
Enclarity and its investors, including Bain Capital and Ignition Capital, engaged TripleTree to help evaluate and assess the Company’s strategic options. Recognizing the significant need for data management, data integrity, and information analytics solutions across multiple healthcare market segments, Enclarity sought a strategic partner with the ability to immediately create new opportunities for their solutions.
Results
After assessing multiple options, Enclarity found LexisNexis to be the ideal partner given their existing analytics platform and commitment to cost containment and transparency. Enclarity will combine with LexisNexis’ Risk Solutions business unit, which offers risk management and fraud prevention products across multiple industries, including healthcare. With the acquisition of Enclarity, LexisNexis becomes a leader in provider data, enabling cost containment through fraud, waste, and abuse prevention and detection while also improving clinical outcomes through identity management, predictive modeling, and clinical analytics.
LEAD INVESTMENT BANKERS
We prioritize your privacy. We do not sell your information and will only send occasional, relevant emails.
TripleTree ©2024 All rights reserved.